Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 21621 | 26.79 |
09:34 ET | 4452 | 26.77 |
09:36 ET | 3311 | 26.7341 |
09:38 ET | 3719 | 26.83 |
09:39 ET | 4788 | 26.93 |
09:41 ET | 3010 | 27 |
09:43 ET | 6105 | 27.02 |
09:45 ET | 8952 | 26.975 |
09:48 ET | 4592 | 26.995 |
09:50 ET | 7405 | 26.92 |
09:52 ET | 6537 | 26.92 |
09:54 ET | 6080 | 26.92 |
09:56 ET | 7209 | 26.8 |
09:57 ET | 6501 | 26.755 |
09:59 ET | 9100 | 26.71 |
10:01 ET | 7036 | 26.73 |
10:03 ET | 3736 | 26.76 |
10:06 ET | 66820 | 26.755 |
10:08 ET | 4341 | 26.73 |
10:10 ET | 4876 | 26.685 |
10:12 ET | 10103 | 26.69 |
10:14 ET | 3613 | 26.685 |
10:15 ET | 2592 | 26.685 |
10:17 ET | 1100 | 26.69 |
10:19 ET | 10076 | 26.705 |
10:21 ET | 1778 | 26.705 |
10:24 ET | 4970 | 26.72 |
10:26 ET | 11043 | 26.695 |
10:28 ET | 12112 | 26.715 |
10:30 ET | 8595 | 26.715 |
10:32 ET | 4106 | 26.75 |
10:33 ET | 7145 | 26.715 |
10:35 ET | 6321 | 26.74 |
10:37 ET | 4129 | 26.72 |
10:39 ET | 1483 | 26.7 |
10:42 ET | 4500 | 26.705 |
10:44 ET | 6083 | 26.69 |
10:46 ET | 7953 | 26.68 |
10:48 ET | 2230 | 26.705 |
10:50 ET | 5646 | 26.705 |
10:51 ET | 4740 | 26.715 |
10:53 ET | 4390 | 26.72 |
10:55 ET | 2735 | 26.705 |
10:57 ET | 7362 | 26.66 |
11:00 ET | 1720 | 26.69 |
11:02 ET | 4301 | 26.685 |
11:04 ET | 3083 | 26.7 |
11:06 ET | 1400 | 26.69 |
11:08 ET | 2167 | 26.71 |
11:09 ET | 2252 | 26.71 |
11:11 ET | 2202 | 26.705 |
11:13 ET | 3912 | 26.735 |
11:15 ET | 3561 | 26.735 |
11:18 ET | 3524 | 26.72 |
11:20 ET | 4506 | 26.73 |
11:22 ET | 1435 | 26.75 |
11:24 ET | 6320 | 26.735 |
11:26 ET | 4685 | 26.7 |
11:27 ET | 1775 | 26.685 |
11:29 ET | 1400 | 26.685 |
11:31 ET | 6392 | 26.625 |
11:33 ET | 6062 | 26.635 |
11:36 ET | 2335 | 26.615 |
11:38 ET | 1734 | 26.605 |
11:40 ET | 9923 | 26.565 |
11:42 ET | 3194 | 26.595 |
11:44 ET | 2966 | 26.58 |
11:45 ET | 3800 | 26.565 |
11:47 ET | 1830 | 26.565 |
11:49 ET | 6286 | 26.54 |
11:51 ET | 10101 | 26.51 |
11:54 ET | 2975 | 26.515 |
11:56 ET | 3982 | 26.5 |
11:58 ET | 6772 | 26.5 |
12:00 ET | 5496 | 26.48 |
12:02 ET | 7976 | 26.455 |
12:03 ET | 3041 | 26.45 |
12:05 ET | 2900 | 26.45 |
12:07 ET | 5350 | 26.43 |
12:09 ET | 9800 | 26.42 |
12:12 ET | 10620 | 26.41 |
12:14 ET | 9257 | 26.415 |
12:16 ET | 7404 | 26.4 |
12:18 ET | 7199 | 26.37 |
12:20 ET | 6372 | 26.34 |
12:21 ET | 17644 | 26.355 |
12:23 ET | 925 | 26.355 |
12:25 ET | 6565 | 26.37 |
12:27 ET | 10945 | 26.33 |
12:30 ET | 10852 | 26.305 |
12:32 ET | 10558 | 26.295 |
12:34 ET | 13628 | 26.285 |
12:36 ET | 2116 | 26.28 |
12:38 ET | 3959 | 26.285 |
12:39 ET | 5430 | 26.295 |
12:41 ET | 10421 | 26.3001 |
12:43 ET | 6289 | 26.315 |
12:45 ET | 5289 | 26.305 |
12:48 ET | 4426 | 26.305 |
12:50 ET | 8757 | 26.31 |
12:52 ET | 1200 | 26.305 |
12:54 ET | 6248 | 26.295 |
12:56 ET | 7487 | 26.26 |
12:57 ET | 7112 | 26.27 |
12:59 ET | 1649 | 26.255 |
01:01 ET | 2877 | 26.245 |
01:03 ET | 2694 | 26.26 |
01:06 ET | 5047 | 26.3 |
01:08 ET | 13371 | 26.31 |
01:10 ET | 1686 | 26.3 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 15.9B | 14.8x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.9x | --- |
Catalent Inc | 10.0B | -8.5x | --- |
Jazz Pharmaceuticals PLC | 7.2B | 23.5x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.2B | 15.7x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.9B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.19% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.8x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | 13.3x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.